Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec;134(6):1175-83.
doi: 10.1542/peds.2014-0177. Epub 2014 Nov 17.

Medication adherence among pediatric patients with sickle cell disease: a systematic review

Kathleen E Walsh  1 , Sarah L Cutrona  2 , Patricia L Kavanagh  3 , Lori E Crosby  4 , Chris Malone  5 , Katie Lobner  6 , David G Bundy  7
Affiliations

Medication adherence among pediatric patients with sickle cell disease: a systematic review

Kathleen E Walsh et al. Pediatrics. 2014 Dec.

Abstract

Objectives: Describe rates of adherence for sickle cell disease (SCD) medications, identify patient and medication characteristics associated with nonadherence, and determine the effect of nonadherence and moderate adherence (defined as taking 60%-80% of doses) on clinical outcomes.

Methods: In February 2012 we systematically searched 6 databases for peer-reviewed articles published after 1940. We identified articles evaluating medication adherence among patients <25 years old with SCD. Two authors reviewed each article to determine whether it should be included. Two authors extracted data, including medication studied, adherence measures used, rates of adherence, and barriers to adherence.

Results: Of 24 articles in the final review, 23 focused on 1 medication type: antibiotic prophylaxis (13 articles), iron chelation (5 articles), or hydroxyurea (5 articles). Adherence rates ranged from 16% to 89%; most reported moderate adherence. Medication factors contributed to adherence. For example, prophylactic antibiotic adherence was better with intramuscular than oral administration. Barriers included fear of side effects, incorrect dosing, and forgetting. Nonadherence was associated with more vaso-occlusive crises and hospitalizations. The limited data available on moderate adherence to iron chelation and hydroxyurea indicates some clinical benefit.

Conclusions: Moderate adherence is typical among pediatric patients with SCD. Multicomponent interventions are needed to optimally deliver life-changing medications to these children and should include routine monitoring of adherence, support to prevent mistakes, and education to improve understanding of medication risks and benefits.

Keywords: medication adherence; sickle cell disease.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Abstracts identified by search strategy and included in final literature review.
See this image and copyright information in PMC

References

    1. Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010;38(4 Suppl):S512–S521 - PubMed
    1. Amrolia PJ, Almeida A, Davies SC, Roberts IAG. Therapeutic challenges in childhood sickle cell disease. Part 2: a problem-orientated approach. Br J Haematol. 2003;120(5):737–743 - PubMed
    1. LeLeiko NS, Lobato D, Hagin S, et al. . 6-Thioguanine levels in pediatric IBD patients: adherence is more important than dose. Inflamm Bowel Dis. 2013;19(12):2652–2658 - PubMed
    1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497 - PubMed
    1. Buchanan GR, Smith SJ. Pneumococcal septicemia despite pneumococcal vaccine and prescription of penicillin prophylaxis in children with sickle cell anemia. Am J Dis Child. 1986;140(5):428–432 - PubMed

Publication types

MeSH terms